[go: up one dir, main page]

UA80831C2 - Sustained-release table composition of pramipexole in a form of an orally deliverable tablet and method of patient treatment - Google Patents

Sustained-release table composition of pramipexole in a form of an orally deliverable tablet and method of patient treatment

Info

Publication number
UA80831C2
UA80831C2 UAA200500638A UA2005000638A UA80831C2 UA 80831 C2 UA80831 C2 UA 80831C2 UA A200500638 A UAA200500638 A UA A200500638A UA 2005000638 A UA2005000638 A UA 2005000638A UA 80831 C2 UA80831 C2 UA 80831C2
Authority
UA
Ukraine
Prior art keywords
pramipexole
sustained
orally deliverable
patient treatment
release table
Prior art date
Application number
UAA200500638A
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Priority claimed from PCT/US2003/023205 external-priority patent/WO2004010997A1/en
Publication of UA80831C2 publication Critical patent/UA80831C2/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

A sustained-release pharmaceutical composition in a form of an orally deliverable tablet comprises a water-soluble salt of pramipexole, dispersed in a matrix comprising a hydrophilic polymer and a starch having a tensile strength of at least about 0.15 kN cm-2 at a solid fraction representative of a tablet.
UAA200500638A 2003-06-18 2003-07-25 Sustained-release table composition of pramipexole in a form of an orally deliverable tablet and method of patient treatment UA80831C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47951303P 2003-06-18 2003-06-18
PCT/US2003/023205 WO2004010997A1 (en) 2002-07-25 2003-07-25 Sustained-release tablet composition of pramipexole

Publications (1)

Publication Number Publication Date
UA80831C2 true UA80831C2 (en) 2007-11-12

Family

ID=39016678

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200500638A UA80831C2 (en) 2003-06-18 2003-07-25 Sustained-release table composition of pramipexole in a form of an orally deliverable tablet and method of patient treatment

Country Status (1)

Country Link
UA (1) UA80831C2 (en)

Similar Documents

Publication Publication Date Title
WO2004010997A8 (en) Sustained-release tablet composition of pramipexole
MY136318A (en) Sustained-release tablet composition
MY130332A (en) Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
JP2005507897A5 (en)
WO2002041837A3 (en) Treatment of mucositis
EP1658849A3 (en) therapeutic combinations of antihypertensive and antiangiogenic agents
FI956014A0 (en) Use of non- and decapeptides in the manufacture of a medicament for the treatment of AIDS
MX2008000099A (en) Modified release pharmaceutical compositions on the basis of two polymers and processes thereof.
GB0211649D0 (en) Organic compounds
EP2813511A3 (en) Ferric organic compounds, uses thereof and methods of making same
CA2251816A1 (en) Sustained release heterodisperse hydrogel systems - amorphous drugs
MX339071B (en) Pregelatinized starch in a controlled release formulation.
NO20072325L (en) Combination therapy including telmisartan and hydrochlorothiazide
TNSN00252A1 (en) PHARMACEUTICAL COMPOSITIONS GENERATING INCREASED CONCENTRATIONS OF DRUGS
EP2172246A3 (en) Methods for Alzheimer's disease treatment and cognitive enhancement
AU2357202A (en) Ion-strength independent sustained release pharmaceutical formulation
WO2004098564A3 (en) Biodegradable nanoparticles comprising an aminoglycoside and a polymer like a polysaccharide
MY137516A (en) Pharmaceutical composition comprising lumiracoxib
WO2002056745A3 (en) Method of treating parkinson's disease
PL1680112T3 (en) N-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin or a pharmaceutically salt thereof for use in the treatment of insulin resistance
DK1643999T3 (en) Pyridoxamine for use in the treatment of diabetic nephropathy in type 2 diabetes
UA80831C2 (en) Sustained-release table composition of pramipexole in a form of an orally deliverable tablet and method of patient treatment
WO2004096155A3 (en) Tablets and methods for modified release of hydrophilic and other active agents
HRP20040165B1 (en) THE USE OF CITALOPRAM IN THE TREATMENT OF INCREASED BLOOD PRESSURE
AU2003294834A1 (en) Anthranilic acid amide derivatives and their pharmaceutical use